Tag: CHMJF

420 with CNW – Cannabis Users Tend to Weigh Less, Study Finds

New research shows that people who use marijuana tend to weigh less than those who don’t. These findings run contrary to a common perception that cannabis users end up becoming obese.

The researchers took data from the National Epidemiologic Survey of Alcohol and Related Conditions and analyzed the BMI (body mass index) of 33,000 participants in the survey.

The analysis showed that out of all the cannabis users, 15 percent could be categorized as obese while the fraction of obese people among non-users of cannabis stood at 20 percent.

The data studied indicated that during the three-year period under scrutiny, all the participants registered an increase in weight. However, that increase was higher among those who didn’t use marijuana.

Granted, the weight difference between cannabis users and non-users was modest. For example, the difference was just two pounds for individuals weighing 200 pounds at the start of the research. However, that difference was observed throughout the study population.

These findings seem to suggest that people who use cannabis consistently have a lower likelihood of becoming obese over the years.

The lead author of the study, Assistant Professor Omayma Alshaarawy, wasn’t certain why those who use marijuana are less likely to become obese.

One of the possible reasons that he advances is that marijuana users may become more conscious about their eating habits due to the “munchies” associated with marijuana consumption. This behavioral factor can then explain why their weight stays in check.

Another possible reason that the researchers present is that marijuana may affect cells or receptors on cells to the extent that the tendency to gain weight is curbed. The researchers weren’t sure about the causative factor for this weight difference, so they called for more research to be done on the matter.

Alshaarawy was also quick to warn that their research should not be used as a reason for people to consume cannabis in order to manage their weight. He cautioned that the full extent of marijuana’s effects on the body hasn’t been understood yet, so people should use other methods of managing their weight instead of consuming cannabis as a weight-management technique.

For those who may be doubtful about the motivation of the researchers, remember that the study was funded by the National Institutes of Health, so there was no motivation to present marijuana in a favorable light.

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) and Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) welcome the research which will help to dispel some of the misconceptions that have surrounded cannabis for long.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Washington State Passes Medical Cannabis in Schools and Marijuana Testing Bills

Two separate cannabis bills have been passed by the Washington state Senate. One has to do with the use of medical cannabis in schools and another regards testing cannabis products before they get on the market.

The bill on medical cannabis in schools is intended to help students with chronic illnesses for which they are being treated using medical marijuana. The bill will allow those students to get their medical cannabis treatment while at school.

More specifically, the treatment will be administered by a parent, and not a school official or a nurse. This provision was intended to eliminate any liability issues that can arise from the administration of medical cannabis to students.

Secondly, the stipulation that only parents can administer medical cannabis to their children at school will also remove any issues that could have arisen regarding the licensing of the people administering medical cannabis to kids.

The senate bill also bans smoking medical cannabis on school premises. Students can therefore only receive medical cannabis edibles and other forms of marijuana. Cannabis products whose THC content is high are also banned from school premises. Most medical cannabis plants are carefully bred to have a high CBD content and very low, if any, THC.

The bill has a trigger clause that allows schools in Washington State to suspend accepting medical marijuana for students once the federal government threatens to cut off the funding of the schools over the medical marijuana program.

In a related development, the senate also passed a bill to modify the marijuana testing requirements of the state. This bill looks at various testing parameters, such as potency, mold, and pesticides.

The lawmakers observed that the existing law had gaps which allowed players in the cannabis industry to make some claims that are hard to verify on their product labels.

The bill wants to transfer oversight of cannabis testing labs from the Liquor and Cannabis Board to the Department of Ecology.

If the bill becomes law, the ecology department will be expected to table new testing guidelines in 2020 and 2021. These guidelines will stem the tide of facilities springing up and claiming to be cannabis testing labs.

The two bills had already got the nod from the state Assembly. The “yes” vote from the senate therefore means that the modified bills will be sent back to the House so that the lawmakers there can approve the changes made by the senators. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) welcome the two bills because they will not only inspire confidence in cannabis products but also make it easy for students to receive their medical cannabis treatment while at school.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Hemp Legalization Could Pave the Way for Marijuana Decriminalization

The Farm Bill of 2018 is getting its final touches to reconcile the versions approved by Congress and Senate. The bill will allow the cultivation of hemp, a plant that has for long been a controlled substance alongside cannabis. Marijuana advocates see the legalization of hemp as a precursor of what will inevitably happen with regard to cannabis since both plants belong to the same family.

Hemp contains just trace amounts of THC (tetrahydrocannabinol) and is rich in CBD (cannabidiol) while cannabis has a high CBD and THC content.

Hemp has often been called “industrial hemp” because of its numerous industrial applications, such as its use in the production of biofuel and in the construction industry. Hemp is also used in the skincare industry as well as having medicinal uses from CBD oil.

Previously, hemp could only be grown if permission was granted in order to get a supply for pre-approved research projects. The new bill will classify hemp as an agricultural product, so one will no longer need a permit to cultivate it.

This decision may look simple at the surface, but it signals a major shift of policy since the new classification would remove the legal stigma of treating hemp as a dangerous plant/substance. It is this undertone that cannabis advocates are counting on for the rescheduling of marijuana since cannabis is closely related to hemp.

It is hoped that cannabis will soon be regarded as an intoxicant that isn’t so dangerous that it deserves the “pariah” status that has been slapped on it for decades.

Economic reasons played a major role in shifting attitudes towards hemp. The diverse uses to which hemp can be placed offer numerous avenues through which local, state and federal authorities can earn tax revenues.

The same prospects exist in the cannabis industry, so there is no reason to think that economic reasons will not come into play as the voices for cannabis legalization get louder across the country and in Congress or Senate.

Descheduling cannabis appears to be taking the same path as same-sex marriages. Society is awakening and questioning whether there is any justification to continue criminalizing cannabis, and the players in the political class are adjusting their positions in light of the shift at the grassroots. Cannabis is no longer the outlier topic it once was.

You can bet that the developments around hemp are of keen interest to companies like Canopy Rivers Inc. (TSX.V: RIV) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) because of the medicinal applications to which CBD can be put.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Change in Attorney General Could Mean a Cannabis Revolution in the US

CannabisNewsWire Editorial Coverage: A new attorney general is still to be named to replace unabashedly anti-cannabis former AG Jeff Sessions. As the market awaits a new AG, there’s a steady push from cannabis companies keeping an eye on the massive potential of the U.S. market, companies that include Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF) (CHMJF Profile), Aurora Cannabis (TSX: ACB) (NYSE: ACB), CannTrust Holdings, Inc. (TSX: TRST), Organigram Holdings, Inc. (TSX.V: OGI) (OTCQX: OGRMF), and Supreme Cannabis Co. (TSX.V: FIRE) (OTCQX: SPRWF) (SPRWF Profile).

To view an infographic of this editorial, click here.

By the end of 2025, the legal cannabis industry is expected to reach $146.4 billion worldwide. Meanwhile, a good number of U.S. companies and investors are being mostly locked out of this booming market because the federal government still classifies cannabis as a Schedule I drug.

However, a sea change of public opinion pointing towards a demand for federal legalization is underway with several states already having voted in favor of cannabis in some form. Even the notoriously conservative, teetotalling state of Utah has joined this revolution.

As Sessions’ replacement has yet to be announced, there is ongoing speculation on the positive benefits of a new face for the cannabis sector. As Forbes magazine puts it, “The new AG will likely be less of an opponent for cannabis simply because it is hard to find someone who has stronger opposition than Mr. Sessions.”

What’s on the table is a massive multibillion-dollar sector that could be unleashed quite quickly should the next AG have a softer and more populist approach to the plant. During the lead-up to a potential legalization, companies large and small are staking their ground in lucrative U.S. regions already brimming with a willing clientele eager to buy legal cannabis.

California alone could bring about a green wave, boasting an existing cannabis market larger than all of Canada combined. Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF) has already begun setting up shop in the Golden State, having recently solidified a land purchase of 9.55 acres in California’s prominent Desert Hot Springs’ cannabis cultivation zone.

Chemistree’s strategic move into California is representative of an early-mover advantage, despite the state’s already booming cannabis sales. California’s cannabis spending hovered near $3 billion in 2017 — even before recreational marijuana became legal on January 1. By 2022, the market in the state is expected to soar to $7.7 billion.

In spite of the legal limbo of cannabis in the United States, the sector’s advantage may already be moving south from Canada into its neighbor to the south. Ahead of the new AG announcement, it appears the U.S. opportunity may have already arrived.

Waking the American Sleeping Giant

Combined, the top U.S. cannabis firms trading on Canadian exchanges represent $8 billion of market value—or roughly 20 percent of the billion-dollar market capitalization of the 144 cannabis companies listed in Canada. This just scratches the surface.

At the moment, the United States lags behind its fellow North American peers in fully capitalizing on the legalization of medical and recreational cannabis. Mexico is moving closer to legalization, with its congress at the beginning of deliberation of a bill to legalize cannabis across the country. During his election campaign, Mexican president-elect Andrés Manuel López Obrador signaled his willingness to consider legalization. Then last week, the country’s Supreme Court ruled that anti-cannabis laws are unconstitutional, forcing lawmakers to decide how to regulate its use.

To the north, Canada — along with Uruguay in South America — has already made recreational use legal. An additional 30 countries and 33 U.S. states, including Australia, Germany and Israel, have legalized some type of cannabis use. Those numbers are growing. More than a dozen countries have already started on the path to full legalization of the plant.

Following the resignation of AG Jeff Sessions, Sessions’ chief of staff, Matthew Whitaker, is presently serving as acting attorney general. Media outlets are speculating who the next AG could be, with New Jersey Governor Chris Christie and Florida AG Pam Bondi leading the way as potential candidates.

While Christie has been adamantly anti-pot in the past, Bondi oversaw the approval of medical marijuana in her state of Florida. A Bondi nomination, coupled with strong public support could ultimately be a major boost for the cannabis sector.

Gearing Up for a New Era

Cannabis companies are already getting their ducks in a row for a new era of legalization. With operations in Washington State and now California, Chemistree is gearing up for a big move.

Upon the announcement of its California land acquisition, Chemistree president Karl Kottmeier stated, “This is a great purchase for Chemistree. I am pleased to report that our highly experienced team in California has begun working on this exciting project. Not only did we arrive at what we believe is a very attractive price, we are buying a site that already has much of the Conditional Use Permit application process well underway. We expect to have the application submitted within the next few weeks and anticipate approval to take 2–3 months thereafter.”

The property is capable of supporting development plans and a Conditional Use Permit application for three 68,000-square-foot cultivation and processing buildings on the site, totaling approximately 205,000 square feet.

Earlier in the year, Chemistree purchased the high-quality, Washington-based Sugarleaf brand with the expressed intent to more than quadruple the reach of its product line through 2019. By taking Sugarleaf’s brand reach across state lines into California, Chemistree is pairing the new brand with its already acquired assets.

Beyond cultivation and branding, Chemistree is also expanding into Northern California. The company has entered into a joint venture on a cannabis processing facility in the north, while also seeking capital to expand locations in the state and broaden its service offerings.

More Red, White, Blue and Green Opportunities

Having recently spun off its American assets into Australis Capital, multinational cannabis producer Aurora Cannabis (TSX: ACB) (NYSE: ACB)  plans to enter the world’s largest economy when relevant laws allow it to do so. While Aurora currently has no direct ownership interest in Australis, the company holds two warrants that would allow it to acquire an ownership interest in Australis if holding investments in U.S. cannabis assets becomes permissible within a decade. In the meantime, Aurora has successfully listed itself on the NYSE.

Soon to be following in Aurora’s NYSE footsteps is CannTrust Holdings, Inc. (TSX: TRST). CannTrust managed to double its sales in Q3, as it prepared to move to the NYSE. While still early in the game, CannTrust delivered sizeable sales growth, and nominal profits. It entered into supply agreements with nine Canadian provinces to supply recreational cannabis across Canada. The company recently launched its fourth recreational brand named “Peak Leaf,” started shipping cannabis oil to Denmark and entered into an exclusive partnership agreement with Kindred Partners, Inc.

Possibly joining the caravan to the NYSE is OrganiGram Holdings, Inc. (TSX.V: OGI) (OTCQX: OGRMF). With a market cap around $600 million, OrganiGram is likely a suitable choice for listing on the NASDAQ exchange, but it could also potentially fit on the NYSE. When it’s finally to scale, OrganiGram will likely be one of the 10 largest cannabis producers in Canada. However, an opening up of the U.S. market would only serve to boost OrganiGram’s already impressive growth curve.

While not actively operating in the United States, Supreme Cannabis Co. (TSX.V: FIRE) (OTCQX: SPRWF) is preparing for entry into the international oils (for medical use) market. Through a partnership with Medigrow located in Lesotho, Supreme is looking to secure international opportunities including Medigrow’s 40,000 litres of cannabis oil potential per year. A loosening of U.S. drug policy could allow groups such as Supreme to import their wares from abroad into the United States and get involved in what could be the largest cannabis market in the world.

For more information on Chemistree, visit Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF)

Please also read and review the article ‘With Cannabis Now Legal in Canada, Investors Are Turning South to the Largest Emerging Cannabis Market in the World’

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Marijuana Tampons to Combat PMS

There has been a push to find natural remedies to the different health challenges that people face. For example, the use of honey has been promoted to treat coughs. And now, marijuana tampons have been made to help women deal with pre-menstrual syndrome (PMS).

A company called Foria is behind the new suppositories that are laced with cannabis. The marijuana in the tampons dissolves inside the vagina after the suppository has been inserted.

Dr. Gendelman explains that the marijuana tampons bring relief from the cramping associated with menstruation. This relief is due to the antispasmodic properties of the cannabis. The effects of the marijuana tampons can last between four and six hours.

Ladies shouldn’t expect the suppositories to eliminate the bloating, but any pain and cramping related to their monthly period will be eliminated or at least reduced significantly. The tampons also help to remove the achiness and loss of appetite associated with menstruation.

What do other doctors think about these suppositories? Many doctors are reluctant to comment about the efficacy of marijuana tampons. They cite the lack of scientific data on such products as the reason behind their reluctance to endorse or dissuade patients from using the tampons.

However, those doctors’ sentiments have not stopped women from trying the products. After all, cannabis has been widely accepted as something that provides pain relief. Why should menstrual pain be an exception, they ask.

Dr. Gendelman advises ladies to be careful about the cannabis tampons that they buy. They should only select products which have been tested by third-parties and found safe for use.

The FDA is yet to approve the suppositories availed by Foria. By the way, Foria also makes other marijuana-based products for women. For example, they have a cannabis lubricant that is reputed to take the sex life of women to new highs.

Perhaps women need to be concerned about the THC in the tampons. The “Relief” tampons, still undergoing medical studies, are said to have about six times more THC than CBD. Therein lies the risk that one could get addicted to cannabis after using the suppositories for a while. Can one remain safe from addiction after using the tampons occasionally?

That question may be one of the issues that the Harvard researchers studying the cannabis tampons may be investigating. We can only hope that the outcomes of the study confirm that marijuana can be used to address menstrual pain without causing any adverse effects, such as triggering addiction. Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF), ChineseInvestors.com (OTCQB: CIIX) and other players in the industry wish the creators of the tampons success in their bid to get FDA approval since that would increase the footprint of cannabis in the lives of people facing various challenges.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Why Companies Are Buying Up Assets in the American Cannabis Market

CannabisNewsWire Editorial Coverage: Canada became the first country in the G8 to legalize recreational cannabis. With all the buzz surrounding Canada’s cannabis boom, savvy investors have begun to assess the U.S. market, focusing on companies such as Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF) (CHMJF Profile), which in July 2018 purchased a suite of physical assets, currently under lease to Sugarleaf Farm LLC, a I-502 Tier 3 licensee located in Sedro Woolley, Washington. This moved was fueled by movement north in Canada, including large Canadian cannabis companies such as Origin House (CSE: OH) (OTCQX: ORHOF) and Namaste Technologies (TSX.V: N) (OTCQB: NXTTF), which  are already seeing major success as their products continue to sell well across the country. While newer entrants in the cannabis industry such as CannTrust Holdings (TSX: TRST) (OTC: CNTTF) and iAnthus Capital (CSE: IAN) (OTCQX: ITHUF) are creating their own product lines and playing catch up with major brands that consumers are already familiar with.

To view an infographic of this editorial, click here.

Establishing Brands Early

Large-scale cannabis legislation has never existed to the extent that it now does in Canada. With major Canadian companies creating brands that resonate with cannabis consumers.

The legal U.S cannabis market is worth an estimated $8.5 billion, claiming 90 percent of the entire $9.5 billion global market. Of that, sales of legal marijuana in Washington State have climbed up to $1.3 billion in the fiscal year 2017, up from $786 million in fiscal 2016, and $259 million the year before. The Canadian market was worth only 6 percent of that $9.5 billion total in 2017. In Canada, competition is heating up as the larger cannabis companies battle for their share of the market. They are relying on their brands and name recognition to help them achieve success.

However, the U.S. cannabis market is shaping up differently. Due to cannabis being federally illegal in the United States, cannabis companies are unable to ship their products across state lines. The unique state-by-state approach to legalization has provided Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF) with an ideal environment to build its brands through the production and sale of premium cannabis in California and Washington. It has also shielded American companies from an influx of foreign product.

Chemistree is another company that is focused on establishing quality brands. The company originally acquired Sugarleaf’s assets in Washington in order to augment its product line with a desirable premium brand. Sugarleaf is already featured in over 50 dispensaries within the state, with estimates suggesting that it will penetrate over 100 stores by 2018 and as many as 200 stores by 2019.

Sugarleaf’s signature White 99 strain has a THC level that registers between 28–32 percent. This is incredibly high even when compared to some of the premium cannabis strains that are being grown in Canada. Sugarleaf’s master grower, Jason Flynn, is one of the many reasons Chemistree chose to acquire the brand. Flynn and his team have won two consecutive cannabis cup competitions for their strains, including the 2014 People’s Choice (Presidential Kush) and 2015 People’s Choice (White 99).

Chemistree also managed to purchase property in the middle of California’s cannabis-friendly Desert Hot Springs for a reasonable $1.23 million. The site is large enough to support up to 205,000 square feet of greenhouses spread out across three facilities. Once fully operational, the company could produce nearly 50,000 pounds of cannabis per year. Desert Hot Springs is a popular cannabis region where there are 3.78 dispensaries for every one thousand people, which is the second highest pot shop density in the state.

Premium Cannabis Is the Real Asset

The demand for premium products exists as cannabis enthusiasts desire THC-rich strains in order to achieve a vivid sensory experience. Growing high-quality cannabis at scale is a challenge that many large producers struggle with as it costs more to produce, and the margin of error is higher.

Health Canada predicts that nearly 2.2 million pounds of cannabis will be consumed within Canada in 2018 alone. The majority of that cannabis will be low- and mid-grade quality, which wholesales for a lot less. Premium cannabis, while more difficult to grow, does provide companies that can grow it with higher profit margins. According to Deloitte, high-quality cannabis could sell for up to 12 percent more than lower quality flower.

The majority of the provinces have supply agreements in place with various licensed producers in the industry. These supply agreements were established in order to provide additional premium cannabis to those provinces.

Demand Will Only Increase

The U.S. cannabis sector is currently in its formative stages. Established companies within the industry that are preemptively laying the framework before the federal government legalizes recreational cannabis should have the ability to build brand recognition and scale them as the floodgates open.

Grand View Research predicts that the global cannabis market could be worth $146.4 billion by 2025. Companies such as Chemistree may be ideally positioned to take advantage of a larger global market because of its focus on building long-term brands that appeal to cannabis users.

Major Players in North American Cannabis

Origin House (CSE: OH) (OTCQX: ORHOF) is focused on creating global brands. It currently holds more than 50 brands including Bhang, Soul Sugar Soul Kitchen and Green Rock Botanicals, among others. The company has a distribution network of 4500plus dispensaries across the United States. With a suite of established brands across key markets in North America, Origin is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke.

CannTrust Holdings (TSX: TRST) (OTC: CNTTF) is a relatively new Canadian cannabis company specializing in medical cannabis products including CBD- and THC-infused capsules and oils. CannTrust recently partnered with Breakthru Beverage Group’s subsidiary company Kindred to secure distribution through the Canadian adult consumer market.

Namaste Technologies (TSX.V: N) (OTCQB: NXTTF) operates the largest global cannabis e-commerce platform with more than 30 websites in 20 countries under various brands. The company product offering through its subsidiaries — such as CannMart Inc., VapeBR, VaporSeller, etc. — includes vaporizers, glassware, accessories, CBD (cannabidiol) products and medical cannabis in the Canadian market.

iAnthus Capital (CSE: IAN) (OTCQX: ITHUF) is a U.S.-based licensed producer and cannabis retail company. iAnthus currently owns a 200,000-square-foot facility in Lake Wales, Florida, and a 4,500-square-foot dispensary in Palm Beach County, Florida. It is also planning to scale to more than 30 locations throughout the state in the coming years.

For more information on Chemistree, visit Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF)

Please also read and review the article ‘With Cannabis Now Legal in Canada, Investors Are Turning South to the Largest Emerging Cannabis Market in the World’

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.